Arkolith/Insider Trading/AKTX/Form 4

Patel Samir Rashmikant

DirectorAkari Therapeutics Plc (AKTX) · full profile →Form 4 · filed Dec 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 2, 2024Grant(A)419.3M—$05.2B

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 2, 2024Grant(A)419.3M—$0419.3M
Nov 30, 2024Grant(A)162.6M—$0162.6M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-132936) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML